Clinical Trials Browser

Phase 2 × OTHER × Leukoplakia, Oral × Clear all

NCT05237960 2026-04-20

Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia

Phase 2 Active not recruiting

Erythroplasia, Leukoplakia, Oral

NCT06876038 2026-03-19

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

Phase 2 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma in Situ, Leukoplakia, Oral, Mouth Neoplasms, Lichen Planus, Oral

NCT07387900 2026-02-06

Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia

Phase 2 Recruiting

Leukoplakia, Oral

NCT05727761 2025-12-24

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Phase 2 Recruiting

Leukoplakia, Oral

NCT03692325 2024-10-01

Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia

Phase 2 Completed

33 enrolled 15 charts

Leukoplakia, Oral

NCT00453336 2017-02-08

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

Phase 2 Completed

45 enrolled 9 charts

Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Leukoplakia, Oral, Precancerous Conditions

NCT00101335 2013-07-11

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Phase 2 Completed

Head & NeckOther neoplasm

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Leukoplakia, Oral, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Tongue Neoplasms

NCT00176566 2009-12-11

A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia

Phase 2 Terminated

Leukoplakia, Oral